Advances in Drug Discovery 2017 Cambridge, England, UK 6-7 March 2017

Description:
Building on the success of our Cambridge Workshop Series, this SELECTBIO conference will feature four tracks: Epigenetics in Drug Discovery; Antibodies in Drug Discovery; Academic Drug Discovery; Stem Cells in Drug Discovery. Delegates have unrestricted access to all conference tracks and networking opportunities.

Epigenetics in Drug Discovery

This track will explore the latest opportunities and challenges for epigeneticists looking to discover and develop new molecular entities.

Topics to be addressed include, assays for Methyltranferases and Demethylases, Bromodomain inhibitor discovery, indications beyond cancer, Non-BET Bromodomains and of course updates in Oncology.

Antibodies in Drug Discovery

This track will fully explore the latest developments in the design and engineering of antibodies in relation to the burgeoning field of biotherapeutics.

Topics to be addressed include, engineering challenges and techniques, new technologies and business hurdles when developing antibodies, the latest developments in autoimmune and infectious disease research.

Academic Drug Discovery

Researchers, group leaders, directors and heads of leading academic and open innovation drug discovery centres will hear about the current challenges and opportunities faced in academic drug discovery.

Prices:
Academic Delegate: GBP 450,
Academic Delegate Early Bird: GBP 399,
Industry Delegate: GBP 750,
Industry Delegate Early Bird: GBP 650,
Pre Doctoral Full Time Student (Inc Poster): GBP 175